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1. Introduction 
In Drosophila, Notch mutations lost a lateral signaling ability and produced a neurogenic 
phenotype, where cells destined to become epidermis switch fate and give rise to neural 
tissue (Artavanis-Tsakonas et al. 1995; Lewis 1998). Therefore, when Notch signaling was 
disrupted, too many neurons were generated. Notch attracted further interest because sel-
12, which appears to facilitate the reception of signaling mediated by lin-12 (C. elegans 
Notch), was identified by screening for a suppressor of lin-12 gain-of-function mutation 
(Levitan and Greenwald 1995). Since sel-12 is thought to be a counterpart of human 
presenilin (PS), which is a catalytic component of -secretase and has been implicated in 
Alzheimer’s disease (AD), it was thought that the Notch signaling pathway might have a 
close relation with AD. Thus, many scientists have investigated the relationship between 
Notch signaling and AD. As we focused below, it has become clear that the Notch signaling 
pathway is controlled by -secretase-mediated proteolysis. 
Both Notch receptors and their ligands are evolutionally conserved single transmembrane-
spanning proteins (type 1 transmembrane protein; amino terminus is extracellular and 
carboxyl terminus is cytoplasmic.) that control the fates of numerous cells in both 
invertebrates and vertebrates (Artavanis-Tsakonas et al. 1995; Artavanis-Tsakonas et al. 1999; 
Justice and Jan 2002). For example, Delta, a major Notch ligand, expressing cells inhibit the 
neural determination of neighboring Notch-expressing neural stem cells (NSCs) during 
neurogenesis (Nakayama et al. 2008a). In addition, it is well known that isoforms of Notch 
mediate somitogenesis, differentiation of lymphoid cells as well as differentiation of NSCs, 
and that dysregulation of Notch signaling causes developmental defects or cancer in 
mammals (Bolos et al. 2007).  
The molecular mechanism of Notch signaling is quite unique in that it is controlled by 
proteolytic cleavage reactions (Artavanis-Tsakonas et al. 1999; Justice and Jan 2002). In the 
canonical Notch signaling pathway, ligands bind to the extracellular domain of Notch on 
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neighboring cells, and trigger sequential proteolytic cleavage. Finally, the intracellular 
domain (ICD) of Notch (NICD) is released from the cell membrane by -secretase and 
translocates to the nucleus to modulate gene expression through binding to transcription 
factors. Therefore, -secretase plays a central regulatory role in Notch signaling. First, we 
give a detailed interpretation of Notch itself and Notch signaling as well as its role in 
differentiation of NSCs. 
The Notch signaling pathway has long been believed to be mono-directional because 
ligands for Notch were generally considered unable to transmit signals into the cells 
expressing them (Fitzgerald and Greenwald 1995; Henderson et al. 1997). However, several 
groups have shown that Delta is cleaved sequentially by proteases, probably including 
ADAM and -secretase (Ikeuchi and Sisodia 2003; LaVoie and Selkoe 2003; Six et al. 2003), 
and ICD of Delta is released from the cell membrane and translocates to the nucleus (LaVoie 
and Selkoe 2003; Six et al. 2003). We have also shown that ICD of mouse Delta binds to 
Smads, which are transcription factors for TGF-/Activin signaling pathway, and enhances 
transcription of specific genes required for neuronal differentiation (Hiratochi et al. 2007). 
These results suggest that Delta also has a signaling mechanism similar to Notch signaling. 
Thus, we also review this issue that the Notch-Delta signaling pathway is bi-directional and 
similar mechanisms regulated by -secretase are involved in both directions of the Notch-
Delta signaling pathway in developing NSCs. 
-Secretase was first identified as a protease that cleaves amyloid precursor protein (APP) 
within the transmembrane (TM) domain and produces A peptides (Haass and Selkoe 
1993), which are thought to be pathogenic in AD (Hardy 1997; Selkoe 2001). However, the 
physiological functions of -secretase have not been clarified (Kopan and Ilagan 2004; Selkoe 
and Wolfe 2007). Recently, it was demonstrated that more than 50 type 1 transmembrane 
proteins, including APP, Notch and Delta, are substrates for -secretase (McCarthy et al. 
2009) and their ICDs are also released from the cell membrane, similar to Notch. These 
observations that the common enzyme, -secretase, modulates proteolysis and the turnover 
of putative signaling molecules have led to the attractive hypothesis that mechanisms 
similar to the Notch signaling pathway may contribute widely to -secretase-regulated 
signaling pathways (Koo and Kopan 2004; Nakayama et al. 2008a; Nakayama et al. 2011). 
Interestingly, it has also been reported that ICD of APP (AICD), which is released from the 
cell membrane by -secretase, translocates to the nucleus (Cupers et al. 2001; Gao and 
Pimplikar 2001; Kimberly et al. 2001) and may function as a transcriptional regulator (Cao 
and Sudhof 2001; Guenette 2002). As the apoptotic potential of AICD has been 
demonstrated, it is likely that APP signaling induces cell death, which leads to AD.  
To explore APP signaling, we established embryonic carcinoma P19 cell lines 
overexpressing AICD (Nakayama et al. 2008b). Although neurons were differentiated from 
these cell lines with all-trans-retinoic acid (RA) treatment, AICD expression induced neuron-
specific apoptosis. The effects of AICD were restricted to neurons, with no effects observed 
on non-neural cells. Furthermore, we evaluated changes in gene expression induced by 
AICD during this process of neuron-specific cell death using DNA microarrays (Ohkawara 
et al. 2011). The results of microarray analysis indicated that AICD induces dynamic changes 
in the gene expression profile. Therefore, it is likely that APP also has a signaling 
mechanism and that AICD may play a role in APP signaling, which leads to AD.  
www.intechopen.com
 γ-Secretase-Regulated Signaling Mechanisms: Notch and Amyloid Precursor Protein 
 
163 
Here, we focus on molecular mechanisms of the Notch-Delta signaling pathway in a bi-
directional manner and discuss the possibility that -secretase-regulated mechanisms similar 
to the Notch-Delta signaling pathway may play a potential role in signaling events 
involving type 1 transmembrane proteins. In addition, we introduce the current topics of -
secretase. We also discuss the possibility that APP signaling induces dynamic changes in 
gene expression, which may be closely correlated with AICD-induced neuron-specific 
apoptosis, leading to AD. 
2. Notch 
2.1 Notch and its ligands 
The typical Notch gene encodes a 300-kD type 1 transmembrane protein with the large 
extracellular domain which contains about 36 tandem epidermal growth factor (EGF)-like 
repeats (Wharton et al. 1985). The 11th and 12th EGF-like repeats are necessary and 
sufficient for binding to its ligands in Drosophila (Rebay et al. 1991). NICD is also large and 
has six tandem ankyrin-like (CDC10) repeats (Wharton et al. 1985). The fundamental 
structures are well conserved throughout evolution, although the numbers of EGF-like 
repeats vary from 10 in C. elegans (Glp-1) (Yochem and Greenwald 1989) to 36 in Drosophila 
and some vertebrate Notch .  
While Drosophila has only one Notch gene, four Notch isoforms (Notch1 to 4) have been 
found in mammals. TAN1 (Notch1), which is a first identified mammalian homolog of 
Notch, was cloned as a gene responsible for human T cell acute lymphoblastic leukemia (T-
ALL) (Ellisen et al. 1991). Notch2 was also cloned as an oncogene of cat thymic lymphoma 
(Rohn et al. 1996). A mutation of the Notch3 gene causes cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (Joutel et al. 
1996), in which the main symptom is cerebral vascular disorder. Interestingly, Notch4 is a 
cellular counterpart of the oncogene of mouse mammary tumor virus (int3) and expresses in 
vascular endothelial cells (Sarkar et al. 1994). 
While Drosophila has two different ligands Delta (Kopczynski et al. 1988) and Serrate 
(Fleming et al. 1990), two families of ligands, Delta family (Delta-like protein: Dll1, 3 and 4) 
(Bettenhausen et al. 1995; Dunwoodie et al. 1997; Shutter et al. 2000) and Jagged family 
(Jagged1 and 2) (Lindsell et al. 1995; Shawber et al. 1996), have been identified in mammals 
to date. C. elegans has two ligands, Lag-2 (Tax et al. 1994) and Apx-1 (Mello et al. 1994). The 
extracellular domains of all these ligands also contain variable numbers of EGF-like repeats; 
for example Drosophila Delta has nine, most vertebrate Deltas have eight, and C. elegans Lag-
2 has two repeats. All of these ligands also share a single copy of a second cysteine-rich 
conservative motif called the DSL (Delta: Serrate: Lag-2) domain (Tax et al. 1994), which is 
essential for binding to Notch (Henderson et al. 1997). In addition, spondylocostal dysostosis 
(SCD), which is characterized by abnormal vertebral segmentation, is caused by mutations 
of Dll3 gene (Sparrow et al. 2002). Alagille syndrome, which is a multi-system disorder 
characterized by paucity of bile ducts and congenital heart disease, is associated with a 
Jagged1 mutation (Oda et al. 1997) as well as a Notch2 mutation (McCright et al. 2002). 
ICDs of all ligands are relatively short compared to those of Notch and it was thought that 
none of ICDs of Notch ligands display any significant sequence similarity throughout 
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evolution (Henderson et al. 1994). As described below, structural evidence supports the idea 
that ICDs of these ligands are non-functional. However, we have revealed that Delta 
homologues display significant sequence similarity, which is restricted to vertebrates, in 
their ICDs (Hiratochi et al. 2007). There is no homology between these vertebrate Deltas and 
Drosophila Delta. In addition, Dll3, a divergent type of Delta, does not show any homology 
to other Delta in ICD. 
2.2 The molecular mechanism of the Notch signaling pathway 
Fig. 1 shows a diagram of the Notch signaling pathway. In the canonical Notch signaling 
pathway, ligands bind to the extracellular domain of Notch on neighboring cells. Both 
Notch (Gupta-Rossi et al. 2004) and its ligands (Itoh et al. 2003) undergo ubiquitin-regulated 
internalization. Mind bomb (Mib) is essential for efficient activation of Notch signaling in 
this step. Mib is a RING-type E3 ubiquitin ligase that ubiquitylates ICDs of Notch ligands 
and promotes internalization of these ligands in a ubiquitination-dependent manner (Itoh et 
al. 2003). As a result of these reactions, conformations of Notch and its ligands may be 
changed by pulling each other to trigger sequential proteolytic cleavages called the 
regulated intramembrane proteolysis (RIP) mechanism (Brown et al. 2000). The RIP 
mechanism requires sequential cleavage steps to occur within the juxtamembrane (JM) and 
TM domains, and these steps are carried out by metalloproteases and -secretase, 
respectively (Selkoe and Kopan 2003). Since precise steps of Notch processing are recently 
made clear and those steps are very similar to that of APP, we mentioned about details of 
these processes in “3.2 Processing mechanisms of several -secretase substrates, such as 
APP, are very similar to that of Notch.”  
Finally, -secretase serves to release NICD from the cell membrane to the cytoplasm and 
released NICD translocates to the nucleus. Thus, -secretase plays a central role in the 
regulation of Notch signaling. Although NICD has a nuclear localization signal and is 
accumulated in the nucleus as an activated form of Notch, mechanisms of the transport of 
NICD from cytoplasm to nucleus have not yet been clarified. 
In the nucleus, NICD binds to transcription factors and controls expressions of certain genes. 
Members of the CSL family (CBF1/RBP-j in mammals, Su(H) in Drosophila and Lag-1 in C. 
elegans) are major downstream transcription factors of Notch signaling (Artavanis-Tsakonas et 
al. 1995; Kimble and Simpson 1997; Artavanis-Tsakonas et al. 1999). NICD binds to CSL 
transcription factors; six tandem ankyrin-like repeats lying in NICD are essential for binding to 
CSL transcriptional factors (Roehl et al. 1996). As NICD also binds to Mastermind-like proteins 
(MAML family in mammals) (Wu et al. 2000), the CSL-NICD-MAML complex is formed. As a 
result of forming these complexes, co-repressors are dispersed from CSL and co-activators 
such as P/CAF and P300 are recruited by these complexes (Wallberg et al. 2002). Therefore, the 
function of CSL complexes is converted from a transcriptional repressor to an activator. 
Finally, activated CSL complexes bind to the cis-acting DNA sequences of target genes and 
enhance the transcriptional activity of these genes. 
The most established target genes for Notch signaling are Hes (Hairy/Enhancer of split in 
Drosophila) genes, which code for the basic helix-loop-helix (bHLH) transcriptional repressor 
for tissue-specific genes (Kageyama et al. 2007). Seven mammalian Hes, designated Hes1 to 
Hes7, have been identified to date, although the mouse does not have Hes4. Hes1 and Hes5 
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bind to their target DNA sequences called N box (CACNAG) by forming homodimers or 
heterodimers with Hey (Hes-related with YRPW motif) 1 or Hey2, and to recruit histone 
deacetylase (HDAC) activity by associating with Groucho, resulting in transcriptional 
repression (Akazawa et al. 1992; Leimeister et al. 1999; Iso et al. 2001). Moreover, they 
associate with E proteins which are ubiquitously expressed bHLH factors and prevent 
proneural bHLH factors, such as Neurogenin, from forming functional complexes with E 
protein (Kageyama et al. 2007). In this manner, Notch represses the differentiation of cells to 
specific lineages. In addition, Delta expression is induced by proneural genes that code for 
bHLH transcriptional factor, although multiple POU-binding factors are also important for 
Delta expression in mammalian NSCs (Nakayama et al. 2004). Thus, Notch signaling 
strongly inhibits Delta expression. 
 
Notch proteins are expressed on the cell surface as heterodimers after cleavage at the S1 site by furin. 
The binding of Notch to the ligand triggers sequential proteolytic cleavage of RIP. When Notch binds to 
the ligand, Notch is cleaved at the S2 site in the juxtamembrane region by TACE or ADAM protease. 
Next, the remaining protein stub is further cleaved by -secretase at the S3 and S4 sites within the 
transmembrane domain and NICD is released from the membrane. Then, NICD translocates into the 
nucleus and binds to the CSL together with MAML. The resultant CSL–NICD–MAML complex 
removes co-repressors from CSL transcription factor and recruits a co-activator, resulting in conversion 
from repressor to activator. Finally, the complexes of CSL-NICD-MAML-co-activators promote 
transcription of the target genes 
Fig. 1. Notch signaling pathway. 
2.3 Notch signaling in the differentiation of NSCs 
The definition of NSCs is that cells can self-renew and are capable of differentiating into 
main phenotypes of the nervous system, such as neurons, astrocytes and oligodendrocytes. 
In mammals, such cells have been isolated from the developing neural tube and more 
recently from the adult brain. Although there are some data showing that Notch signaling 
plays a role in the adult NSCs, a large majority of evidence for Notch signaling in 
controlling NSCs differentiation comes from analysis of embryonic neurogenesis. 
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In the developing mammalian central nervous system, NSCs repeat self-renewal by 
symmetric cell division to increase the total number of NSCs as a first step 
(NSCs/progenitor cells expansion phase). In this phase, Notch signaling is thought to 
maintain those NSCs in the proliferating and undifferentiating state (Fortini 2009; Kopan 
and Ilagan 2009; Pierfelice et al. 2011). Recently, it has been shown that expression of Hes1, 
the target genes for Notch signaling, oscillates with a period of about 2 hours in this phase 
(Kageyama et al. 2007). Hes1 expression may induce the oscillatory expression of Dll1 gene 
and the proneural Neurogenin2 (Ngn2) gene by periodic repression. Thus, concentrations of 
Dll1 mRNA and both Ngn2 mRNA and protein also oscillate with an inverse correlation 
with Hes1 (Kageyama et al. 2008; Shimojo et al. 2011). It is thought that Ngn2 cannot induce 
differentiation of neuron when Ngn2 expression oscillated and Dll1 leads to the activation of 
Notch signaling to maintain NSCs in proliferating state. 
In next phase (neurogenic phase), NSCs undergo asymmetric cell division, where each NSC 
divides into two distinct types, NSC and neuron. In this phase, oscillatory expressions of 
Hes1 disappear (Kageyama et al. 2008; Shimojo et al. 2011). Since Hes1 expression is 
repressed, Dll1 and Ngn2 are constitutively expressed in a sustained manner and Ngn2 
induces neuronal differentiation. Although the role of Notch signaling is not well 
understood, numb, which is an antagonist of Notch signaling (Frise et al. 1996; Guo et al. 
1996; Spana and Doe 1996), is thought to be a critical component of NSCs asymmetrical 
division. During NSC divisions in this phase, numb appeared to be asymmetrically 
distributed to the neuronal daughter cells and was absent in undifferentiated NSCs (Zhong 
et al. 1996; Zhong et al. 1997; Chenn 2005). Thus, these observations suggest that numb 
inhibits Notch signaling and promotes differentiation to neuron in the neuronal daughter 
cells. After the generation of neurons, NSCs differentiate into oligodendrocytes and 
ependymal cells, followed by differentiation into astrocytes (gliogenic phase). 
Recently, it has been shown that Notch signaling may also play an essential role in 
maintenance and differentiation of adult NSCs (Imayoshi and Kageyama 2011). Usually, 
adult NSCs are in the dormant state (quiescent state) and Notch signaling may maintain this 
state of adult NSCs. It is thought that NSCs turn from dormant state into dividing state, 
when the activity of Notch signaling falls down. Thus, Notch signaling controls the balance 
between dormant state and differentiation state of adult NSCs. 
2.4 Delta signaling may be involved in neuronal differentiation 
The Notch signaling pathway has long been thought to be mono-directional because ligands 
for Notch were generally considered unable to transmit signals into cells expressing these 
ligands (Henderson et al. 1994; Fitzgerald and Greenwald 1995). Indeed, it was thought that 
none of ICDs of putative Notch ligands display any significant sequence similarity throughout 
evolution (Henderson et al. 1994). Moreover, replacement of most of ICD of LAG-2, a C. elegans 
lin-12 (Notch) ligand, with a -galactosidase fusion protein has no discernible effect on LAG-2 
function (Henderson et al. 1994). In contrast, however, it has been reported that the 
extracellular domain of Notch expressed in the mesoderm provided a positive signal to the 
overlaying ectoderm in Drosophila as mentioned below (Baker and Schubiger 1996). Since these 
observations suggest that signaling in the opposite direction also exists, the important and 
critical question is whether signaling events occur not only from ligand-expressing cells to 
Notch-expressing cells but also vice versa, i.e., in a bi-directional manner. 
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Recently, evidence has been accumulating in support of a functional role of ICD of Notch 
ligands, which implies the existence of bi-directional signaling mechanisms. For example, 
Delta has been shown to release ICD from the cell membrane when cleaved by ADAM 
protease and -secretase (Qi et al. 1999; Ikeuchi and Sisodia 2003; LaVoie and Selkoe 2003; 
Six et al. 2003). Several groups have reported evidences supporting the nuclear localization 
of Delta ICD (Bland et al. 2003; LaVoie and Selkoe 2003; Six et al. 2003). These observations 
suggest that Delta ICD is released from the cell membrane by RIP. Indeed, we have shown 
that Delta homologues display significant sequence similarity, which is restricted to 
vertebrates, in their ICDs (Hiratochi et al. 2007). It is likely that conservation of these amino 
acid sequences reflect the functional importance of Delta ICD.  
To clarify the question of whether the Notch-Delta signaling pathway is bi-directional, we 
investigated the effect of Notch on differentiation of NSCs isolated from mouse embryos 
(Hiratochi et al. 2007). When NSCs were co-cultured on a monolayer of mouse Dll1-
expressing COS7 cells, the rate at which neurons emerged was lower than that in controls. 
As mentioned above, Notch signaling maintains the proliferating and undifferentiating state 
of NSCs and inhibits the differentiation into neurons (Fortini 2009; Kopan and Ilagan 2009; 
Pierfelice et al. 2011). Therefore, these observations indicate that Dll1 on COS7 cells 
generates signals to neighboring NSCs that express Notch and thus activates Notch 
signaling. Conversely, when NSCs were co-cultured on a monolayer of mouse Notch1-
expressing COS7 cells, the rate of neurons developing from NSCs was significantly higher 
than that in control cultures. These results suggest that Notch1 on COS7 cells may also 
generate signals to neighboring NSCs and these ligands, probably Delta, may then transmit 
signals into cells expressing them to promote neuronal differentiation. Thus, signaling 
events may occur not only from Delta-expressing cells to Notch-expressing cells but also 
vice versa, that is, in a bi-directional manner, during differentiation of NSCs. Indeed, Baker 
and Schubiger published results from a mosaic experiment in Drosophila, which showed that 
expression of Notch in the mesoderm of Notch mutant suppressed the ectodermal defects of 
this mutant (Baker and Schubiger 1996). This effect was inferred to be due to the 
extracellular domain of the protein and not its signaling function, since activated Notch 
failed to produce non-autonomous suppression (Baker and Schubiger 1996). These results 
indicate that the extracellular domain of Notch expressed in the mesoderm sent a positive 
signal to the overlying ectoderm. Thus, these observations further support the hypothesis 
that Notch-expressing cells also send a signal to Delta-expressing cells.  
2.5 Delta ICD may modify expression of certain genes 
The nuclear localization of Delta ICD suggests that this domain may have effects on the 
transcription of a specific target gene similar to NICD. To examine this possibility, we 
searched for transcriptional factors capable of binding to ICD of Dll1 (Dll1IC) using a new 
method and identified Smads as a Dll1IC binding transcription factor through the 
differentiation process of mouse NSCs (Hiratochi et al. 2007). 
Smads are transcription factors and have been shown to act as mediators of signaling by the 
TGF- superfamily. Eight Smads, designated Smad1 to Smad8, have been identified to date 
in mammal (Miyazawa et al. 2002; Derynck and Zhang 2003). Smad2 and Smad3 are 
activated by TGF- and activin (Eppert et al. 1996; Zhang et al. 1996; Nakao et al. 1997), while 
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Smad1 and Smad5 are major components that are activated by bone morphogenic proteins 
(BMPs) (Hoodless et al. 1996; Kretzschmar et al. 1997; Suzuki et al. 1997). Although Smad1 
and Smad5 did not bind to Dll1IC, Smad2 and Smad3 showed strong binding (Hiratochi et 
al. 2007). These observations indicate that Dll1IC can modify TGF-/Activin signaling 
through binding to Smad2 and/or Smad3. However, BMP signaling, which is known to 
inhibit neurogenesis and to enhance the appearance of astrocytes, may not be affected by 
Dll1IC, because Dll1IC did not bind to Smad1 or Smad5. 
 
Notch receptor also generates signals to Delta expressed on the surface of neighboring NSCs. Delta is 
cleaved sequentially by proteases, probably including ADAM and -secretase, and finally the intracellular 
domain of Delta (DeltaIC) is released from the cell membrane and translocates to the nucleus, where it 
mediates TGF-/Activin signaling through binding to Smad2/3 and enhances transcription of specific 
genes leading to neuronal differentiation. It is well known that NICD is also released from the cell 
membrane by proteases similar to the ones involved in the cleaving of Delta, then translocates to the 
nucleus to modulate gene expression through binding to the transcription factor, that is, Suppressor of 
Hairless (Su(H), RBP-j in mammals) together with MAML. This means that similar mechanisms are 
involved in both directions of the bi-directional Notch-Delta signaling pathway. BMPs, another group 
belonging to the TGF- superfamily, have recently been shown to inhibit neurogenesis and to enhance the 
generation of astrocytes from NSCs. It has also been demonstrated that NICD and activated Smad1/5 form 
a complex with p300 in the specific promoter sequence, which contains both the RBP-j and Smad binding 
sequences. It is therefore possible that the TGF- superfamily mediates both neurogenesis and gliogenesis 
from NSCs coupled with the bi-directional Notch-Delta signaling pathway. 
Fig. 2. Schematic of the bi-directional model of Notch-Delta signaling pathway in the 
process of NSC differentiation. 
Although we have yet to determine the actual target genes for the Dll1IC-Smad complex, we 
showed that binding of Dll1IC to Smad enhanced its transcriptional activity using the 
9XCAGA-Luc promoter-reporter system that responds specifically to Smad3 (Dennler et al. 
1998; Jonk et al. 1998), as a model system. These results strongly suggest that Dll1IC 
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mediates transcription of certain genes, which are targets of TGF-/Activin signaling, 
through binding to Smad2 and/or Smad3. 
As mentioned above, it is likely that Delta transmits signals into NSCs expressing them to 
promote neuronal differentiation. To test this possibility, we established embryonic carcinoma 
P19 cells stably overexpressing Dll1IC (Hiratochi et al. 2007). Although control P19 cells have 
been shown to be induced to differentiate into neurons, RA stimulation is essential for the 
induction of neurons from these P19 cells. However, neurons could be induced from P19 cells 
stably overexpressing Dll1IC without RA stimulation and this induction was strongly 
inhibited by SB431542, a specific inhibitor of TGF- type1 receptor (Laping et al. 2002) that 
activates Smad2 and Smad3. These results suggest that overexpression of Dll1IC in P19 cells 
induced neurons through binding to Smad2 and/or Smad3. Therefore, it is highly possible 
that Delta signaling also plays an important role in neuronal differentiation. Recently, it has 
been reported that TGF- inhibits proliferation and accelerates differentiation of the 
hippocampal granule neuron (Lu et al. 2005). This observation also supports our hypothesis. 
A schematic model of Notch-Delta signaling pathway in the process of NSC differentiation 
is shown in Fig. 2. 
3. -Secretase 
3.1 Overview of -secretase 
-Secretase was first identified as a protease that cleaves APP within the TM domain and 
produces A peptides (Haass and Selkoe 1993), which are thought to have pathogenic roles 
in AD. However, the physiological functions of this enzyme have not been clarified (Kopan 
and Ilagan 2004; Selkoe and Wolfe 2007). The -secretase is a complex composed of PS, 
nicastrin (NCT), anterior pharynx defective-1 (Aph-1), and PS enhancer-2 protein (Pen-2) 
(Iwatsubo 2004; Kopan and Ilagan 2004; Selkoe and Wolfe 2007). PS is a catalytic component 
of the -secretase complex, and the two PS genes, PS1 gene (PSEN1) (Sherrington et al. 1995) 
located on chromosome 14 and PS2 gene (PSEN2) (Levy-Lahad et al. 1995; Rogaev et al. 1995) 
located on chromosome 1, were identified by genetic linkage analyses as the genes 
responsible for several forms of early-onset familial AD (FAD). PSEN1 and PSEN2 encode 
polytopic transmembrane proteins of 467 and 448 amino acids, respectively, which show 
about 65% sequence identity between the two proteins. While PS1 expression level is higher 
than that of PS2, both proteins are expressed ubiquitously in the brain and peripheral tissues 
of adult mammals (Lee et al. 1996). The model for PS with eight or nine transmembrane 
domains is generally accepted and PS has a hydrophilic loop domain between the putative 
6th and 7th transmembrane domains facing the cytoplasm (Doan et al. 1996) and is cleaved 
by an unidentified protease within this loop resulting into two fragments, N- and C- 
terminal fragment (NTF and CTF), that remain associated as a heterodimer (Thinakaran et 
al. 1996). This proteolytic cleavage is thought to occur when nascent PS assembles with 
NCT, Aph-1, and Pen-2 as a -secretase complex and activates PS as the catalytic component 
of aspartyl protease (Iwatsubo 2004; Kopan and Ilagan 2004; Selkoe and Wolfe 2007). 
The single-pass membrane protein NCT may recognize the substrate proteins of -secretase 
(Yu et al. 2000; Shah et al. 2005). The extracellular domain of NCT resembles an 
aminopeptidase, but lacks catalytic residues, and can interact with the N-terminal stubs of -
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secretase substrates after ectodomain shedding (Shah et al. 2005). Thus, shedding of 
membrane proteins may be essential for the production of free N-termini of these proteins 
retained in the membrane, which can then be recognized by NCT. Aph-1 is thought to act as 
a scaffold during the process of -secretase complex assembly, and Pen-2 was suggested to 
act as a trigger for the proteolytic cleavage of PS to regulate PS activity (Kopan and Ilagan 
2004; Selkoe and Wolfe 2007). 
3.2 Processing mechanisms of several -secretase substrates, such as APP, are very 
similar to that of Notch 
Precise steps of Notch processing are recently made clear (Fig.3). After translation, Notch is 
cleaved by furin-like covertase at the S1 site in the trans-Golgi network, and the two 
resulting fragments remain associated to form a functional heterodimer that is expressed on 
the cell surface (Logeat et al. 1998). 
 
(A) In response to ligand binding, Notch undergoes shedding due to metalloprotease cleavage at the S2 
site within the JM domain. After shedding the extracellular domain, the remaining Notch stub is further 
cleaved by -secretase at S3 and S4 sites within the TM domain. This sequential proteolysis produces 
NICD and N fragment. (B) Cleavage of APP by -secretase or -secretase at the -site or -site, 
respectively, within the JM domain results in shedding of almost the entire extracellular domain and 
generates membrane-tethered - or -carboxy terminal fragments (CTFs). Several zinc 
metalloproteinases and BACE2 can cleave APP at the -site, while BACE1 cleaves APP at the -site. 
After shedding the extracellular domain, the remaining stub is further cleaved at least twice within the 
TM domain at - and -sites by -secretase, producing either p3 peptide (in combination with -
secretase) or A (in combination with BACE1), respectively, and AICD. (C) Several stimuli, such as PKC 
activation and Ca2+ influx, trigger ectodomain cleavage of CD44 by a metalloprotease at the site within 
the JM domain, resulting in the secretion of soluble CD44 (sCD44). After shedding the extracellular 
domain, the remaining CD44 stub is further cleaved by -secretase at two sites within the TM domain. 
This sequential proteolysis produces the CD44 ICD and CD44, an A-like peptide. 
Fig. 3. Similarities in the proteolytic processes among Notch, APP, and CD44.  
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As mentioned above, the sequential proteolytic cleavage called RIP mechanism is initiated 
by ligand binding and shedding at the S2 site by TACE or ADAM protease making the 
truncated Notch (Pan and Rubin 1997; Brou et al. 2000). Truncated Notch is further cleaved 
by -secretase in at least two sites within the TM domain, i.e., at the S3 site to release NICD 
and at the S4 site to release the remaining small peptide (N) (Kopan et al. 1996; Schroeter et 
al. 1998; Okochi et al. 2002), which resembles A. 
The proteolytic process of APP resembles that of Notch and also follows the RIP mechanism 
(Fig.3). Cleavage of APP by -secretase (Esch et al. 1990) or -secretase (Vassar et al. 1999) at 
the -site or -site, respectively, within the JM region results in shedding of almost the 
entire extracellular domain and generates membrane-tethered - or - CTFs. Several zinc 
metalloproteinases (Buxbaum et al. 1998; Lammich et al. 1999) and the aspartyl protease 
BACE2 can cleave APP at the -site (Farzan et al. 2000), while BACE1 (-site APP cleaving 
enzyme) cleaves APP at the -site (Vassar et al. 1999). After shedding, the remaining stub is 
further cleaved at least twice by -secretase within the TM domain at - and -sites resulting 
in production of either non-amyloidogenic p3 peptide (in combination with -secretase) or 
amyloidogenic A (in combination with BACE1), respectively, and AICD (Kopan and Ilagan 
2004; Selkoe and Wolfe 2007). In addition, AICD was shown to be a substrate of caspase and 
to be cleaved at the group III caspase consensus sequence 16 amino acids from the 
membrane border within the AICD. 
It has been reported that several -secretase substrates also follow the RIP mechanism with 
release of their ICDs from the cell membrane. As shown in Fig. 3, the process of sequential 
proteolytic cleavage of CD44, which is important for immune system function, is very 
similar to those of Notch and APP and follows the RIP mechanism (Nagase et al. 2011). In 
addition, the ICD of this protein (CD44ICD) is also translocated to the nucleus, suggesting 
that CD44ICD may also mediate the gene expression. 
3.3 Does -secretase mediate signaling events of type 1 transmembrane proteins? 
-Secretase seems to cleave a diverse set of type1 transmembrane proteins, which have been 
shed their extracellular domains, in a sequence-independent manner (Struhl and Adachi 
2000). As reflected by the flexible sequence specificity of -secretase activity, more than 50 
type 1 transmembrane proteins have been reported as substrates of -secretase (McCarthy et 
al. 2009). As shown in Table 1, these substrates also have a wide range of functions, 
including roles in cell differentiation (Notch, Delta, and Jagged), cell adhesion (N-cadherin, 
E-cadherin, and CD44), synaptic adhesion (Nectin-1), ion conductance regulation (voltage-
gated sodium channel 2 subunit), axon guidance and tumor suppression (DCC), 
neurotrophin receptor (P75NTR), and its homolog (NRADD), lipoprotein receptor 
(ApoER2), and growth factor-dependent receptor tyrosine kinase (ERBB4).  
As mentioned above, proteolytic cleavages of several -secretase substrates, such as APP and 
CD44, follow the RIP mechanism. The ICDs of these substrates are released from the cell 
membrane to cytoplasm by -secretase, and finally these ICDs translocate to the nucleus. These 
processes are very similar to those involved in Notch signaling. Thus, the observations that the 
common enzyme, -secretase, modulates proteolysis and the turnover of possible signaling 
molecules led to the signaling hypothesis suggesting that mechanisms similar to those 
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occurring in the Notch signaling pathway may contribute widely to -secretase-regulated 
signaling pathways (Koo and Kopan 2004; Nakayama et al. 2008a; Nakayama et al. 2011). 
Indeed, as mentioned above, Dll1 is cleaved sequentially by proteases, probably including 
ADAM and -secretase, and Dll1IC is released from the cell membrane and undergoes 
translocation to the nucleus (Hiratochi et al. 2007). In the nucleus, Dll1IC enhances 
transcription of specific genes through binding to Smads. These observations suggest that 
Dll1 may also have a signaling mechanism similar to Notch signaling. 
 
Substrate Function PS or ICD function
ApoER2 Lipoprotein receptor, 
neuronal migration
Activate nuclear reporter
APP Precursor to A, adhesion, 
trophic properties, axonal 
transport?
A generation, release of ICD,  
complex with Fe65/Tip60, Cell death? 
APLP1/2 Cell adhesion? Form complex with Fe65 and Tip60 
E-cadherin Cell adhesion Promote disassembly of adhesion 
complex
N-cadherin Cell adhesion Promote CBP degradation
-catenin Transduce Wnt signals 
stabilize adherens junctions
Facilitate phosphorylation
CD43 Signal transduction Signaling molecule?
CD44 Cell adhesion Activate TRE-mediated nuclear 
transcription
CSF1-R Protein tyrosine kinase Unknown
CXCL16 & CX3CL1 Membrane chemokine 
ligands
Unknown
DCC Axon guidance, tumor 
suppressor
Activate nuclear reporter
Delta Notch ligand Transcription regulation
ERBB4 Receptor tyrosine kinase Regulate heregulin-induced growth 
inhibition
HLA-A2 MHC class I molecule Unknown
IGIF-R Receptor tyrosine kinase Unknown
IFN-R2 Subunit of type I IFN- 
receptor
Transcriptional regulation
IL-1RI Cytokine receptor Unknown
IL-1RII Cytokine receptor Unknown
Jagged Notch ligand Modulate AP-1 mediated transcription 
LDLR Lipoprotein receptor Unkown
LRP Scavenger and signaling 
receptor
Activate nuclear reporter
Na channel -
subunit 
Cell adhesion, an auxiliary 
subunit of voltage-gated Na 
channel
Alter cell adhesion and migration 
Nectin-1 Adherens junction, synapse 
receptor
Remodeling of cell junctions? 
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Substrate Function PS or ICD function
Notch1-4 Signaling receptor Transcription regulation
NRADD Apoptosis in neuronal cells Modulate glycosylation/matutaion of 
NRADD
P75NTR Neurotrophin co-receptor, 
dependence receptor
Modulate p75-TrkA complex? 
Nuclear singaling?
-protocadherin Cell adhesion, neuronal 
differentiation
Regulation of gene transcription? 
Syndecan-3 Cell surface proteoglycan co-
receptor
Regulation of membrane-targeting of 
CASK
Telencephalin Cell adhesion Turnover of telencephalin
Tyrosinase,  
Tyrosinase-related 
protein 1/2 
Pigment synthesis Intracellular transport of Post-Golgi Tyr-
containing vesicles 
PS, presenilin; ICD, intracellular domain; APLP, APP like protein; CBP, CREB (cAMP-responsive 
element binding protein)-binding protein; TRE, TPA (12-o-tetradecanoylphorbol 13-acetate)-responsive 
element; AP-1, activator protein-1; CASK, calmodulin-dependent serine kinase; Tyr, Tyrosinase. 
Table 1. Substrates for -secretase 
3.4 Is -secretase a proteasome of the membrane? 
As mentioned above, more than 50 type 1 membrane proteins have been reported as 
substrates of -secretase. This observation raises the simple question of why so many 
membrane proteins can transmit signals to the nucleus. In contrast to the signaling 
hypothesis, Kopan and Ilagan proposed another possibility that -secretase may act as a 
proteasome for membrane proteins (Kopan and Ilagan 2004). They pointed out that 
generally the ICDs of these substrates including AICD, which are released by -secretase, are 
rapidly degraded. Moreover, ectodomain shedding seems to be constitutive for some 
substrates, and ligand binding has been reported to enhance only intramembrane cleavage 
of Notch (Schroeter et al. 1998), Delta (Hiratochi et al. 2007), Syndecan-3 (Schulz et al. 2003), 
and ERBB4 (Ni et al. 2001). In addition, they also pointed out that the most evidence 
supporting the signaling hypothesis was obtained in overexpression experiments that differ 
somewhat from physiological conditions. Based on these observations, they proposed the 
proteasome hypothesis that the primary function of -secretase is to facilitate the selective 
disposal of type 1 membrane proteins (Kopan and Ilagan 2004). 
While the proteasome hypothesis of -secretase is reasonable, there is no doubt that -
secretase regulates signaling pathways of some substrates, such as Notch (Artavanis-
Tsakonas et al. 1999; Selkoe and Kopan 2003; Koo and Kopan 2004). Although further studies 
are required to elucidate this issue, it is likely that -secretases are not uniform complexes 
but that different -secretase complexes may exist in different combinations with 
components such as Aph-1, Pen2, and/or PS isoforms, with different cellular functions, such 
as roles in signaling or degradation (Kopan and Ilagan 2004). Since -secretase substrates 
such as APP are generally more abundant than transcription factors, which are usually rare 
molecules, it is uncertain whether the majority of the ICDs of these substrates released by -
secretase are required for the signaling mechanisms (Nakayama et al. 2008a; Nakayama et al. 
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2011). Although a large proportion of ICDs of these substrates are rapidly degraded, it is 
likely that a small amount of the remaining ICDs may be suitable for their functions with a 
small quantity of transcription factors. Thus, the greater part of ICDs of these substrates may 
be degraded and only a small proportion may play a role in signaling. 
 
After cleavege of JM domain by - or -secretase, AICD is released from the membrane by -secretase. 
Non-phosphorylated AICD binds to the nuclear adaptor protein Fe65, which is thought to be essential 
for translocation of AICD to the nucleus, and forms complexes, alone or with the histone 
acetyltransferase Tip60. These complexes can immediately translocate to the nucleus, where they 
meidate up- and downregulation of certain target genes in association with Tip60. On the other hand, 
phospholylated AICD cannot translocate to the nucleus due to the inhibition of binding to Fe65, leading 
to rapid degradation by the proteasome and/or insulin-degrading enzyme (IDE). 
Fig. 4. Putative APP signaling pathway.  
In relation to this issue, an attractive model has been proposed (Fig.4) (Buoso et al. 2011). 
Binding to nuclear adaptor protein Fe65 is thought to be essential for translocation of AICD to 
the nucleus. In this model, since non-phosphorylated AICD binds to Fe65 and forms 
complexes, these complexes can immediately translocate to the nucleus, where they control the 
expression of certain genes in association with the histone acetyltransferase Tip60. On the 
other hand, as other stimuli induce phosphorylation of AICD, which strongly inhibits binding 
to Fe65, AICD without Fe65 cannot translocate to the nucleus. Phosphorylated AICD left in the 
cytosol is rapidly degraded, most likely by the proteasome and/or insulin-degrading enzyme 
(IDE) (Edbauer et al. 2002). Indeed, it has been reported that when phosphorylated at Thr668 in 
the APP-695 isoform, AICD cannot bind to Fe65 (Kimberly et al. 2005). 
4. APP signaling? 
4.1 Overview of APP 
APP was first identified as a cDNA cloned using a partial amino acid sequence of A 
fragment from the amyloid plaque of AD brains (Kang et al. 1987). APP is a type 1 
membrane protein expressed in many tissues, especially concentrated in the synapses of 
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neurons. In humans, the APP gene contains at least 18 exons in a total length of 240 kb 
(Yoshikai et al. 1990), and several alternative splicing isoforms of APP have been observed, 
differing mainly in the absence (APP-695 which is predominately expressed in neurons) or 
presence (APP-751 and APP-770) of a Kunitz protease inhibitor (KPI) domain located 
toward the N-terminus of the protein (Sisodia et al. 1993). As mentioned above, APP 
undergoes sequential proteolytic cleavage reactions to yield the extracellular fragment, 
intracellular fragment (AICD), and A fragment located in the membrane-spanning domain, 
which is thought to be the main cause of the onset of AD. 
While APP has central roles in AD (Hardy 1997; Selkoe 2001), the physiological functions of 
this protein also remain to be clarified (Zheng and Koo 2006). It has been reported that APP 
acts as a cell adhesion molecule for cell-cell interaction (Soba et al. 2005), and as a 
neurotrophic and/or synaptogenic factor (Hung et al. 1992; Bibel et al. 2004; Leyssen et al. 
2005). In addition, the possibility that APP is a cell-surface receptor is interesting from the 
signaling perspective. Several evidences support this idea; e.g., A can bind to APP and thus 
may be a candidate ligand for APP (Lorenzo et al. 2000). It has also been reported that F-
spondin (Ho and Sudhof 2004) and Nogo-66 receptor (Park et al. 2006) could bind to the 
extracellular domain of APP and regulate A production. Furthermore, the extracellular 
domain of APP may potentially interact in trans suggesting that APP molecules can bind to 
each other (Wang and Ha 2004). 
APP homologs show significant evolutionary sequence conservation in ICD (Nakayama et 
al. 2008b), which may reflect the functional importance of AICD. However, the A region of 
this protein is not well conserved across species. As mentioned, AICD is thought to form 
complexes with Fe65 and these complexes translocate to the nucleus. In the nucleus, these 
complexes may associate with Tip60 and may bind to the cis-acting DNA sequence of the 
tetraspanin protein KAI1 gene to control transcriptional activity (Baek et al. 2002).  
4.2 AICD induces neuron-specific apoptosis 
There is accumulating evidence in support of the idea that APP signaling exists and 
contributes to the onset of AD. For example, transgenic mice overexpressing both AICD and 
Fe65 showed abnormal high activity of glycogen synthase kinase 3 beta (Gsk3b protein) 
(Ryan and Pimplikar 2005), leading to hyperphosphorylation and aggregation of TAU, 
resulting in microtubule destabilization, and reduction of nuclear -catenin levels causing a 
loss of cell-cell contact mechanisms that may give rise to neurodegeneration in AD brain. In 
addition, it was also shown that c-Abl modulates AICD-dependent transcriptional 
induction, as well as apoptotic responses (Vazquez et al. 2009). Interestingly, elevated AICD 
levels have also been observed in AD brains (Ghosal et al. 2009). Therefore, it is highly 
possible that APP signaling changes expression patterns of certain genes and induces cell 
death, which may lead to AD pathology. 
To explore APP signaling, we established several AICD-overexpressing embryonic 
carcinoma P19 cell lines (Nakayama et al. 2008b). Although neurons were differentiated 
from these cell lines after aggregation culture with RA treatment, AICD expression induced 
neuron-specific cell death. Indeed, while neurons from control cells which carried vector 
alone were healthy, almost all neurons from AICD-overexpressing P19 cells showed severe 
degeneration four days after induction of differentiation (Fig. 5). Moreover, DNA 
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fragmentation was detected, and all of terminal deoxynucleotidyl transferase (TdT)-
mediated deoxyuridine triphosphate (dUTP)-biotin nick end-labeling (TUNEL)-positive 
cells were also Tuj1-positive neurons. Based on these observations, we concluded that AICD 
can induce neuron-specific apoptosis (Nakayama et al. 2008b). The effects of AICD were 
restricted to neurons, with no effects observed on non-neural cells. Thus, although further 
studies are required, these results strongly suggest that AICD plays a role in APP signaling, 
which leads to the onset of AD. 
 
After aggregation culture with RA, AICD-overexpressing P19 and control P19 cells carrying vector alone 
were replated and cultured for the indicated periods on dishes and allowed to differentiate. 
Undifferentiated AICD-overexpressing P19 cells retained epithelial cell-like morphology similar to control 
cells, while the differentiated cells became round and showed a bipolar morphology with neurite 
extension. Two days after replating (Day 2), all cell lines grew well and neurons with long neurites 
appeared. Four days after replating (Day 4), control cells still grew well as clusters and many neurons had 
differentiated from these cells. However, many AICD-overexpressing P19 cells showed severe 
degeneration, becoming spherical with numerous vacuoles and detached from the culture dishes. 
Fig. 5. Overexpression of AICD in P19 cells induces neuronal cell death.  
4.3 AICD induces dynamic changes in the gene expression profile 
If APP signaling exists, AICD should change expression of certain genes. To test this 
hypothesis and identify the genes involved in this process of neuron-specific apoptosis, we 
employed both AICD-overexpressing P19 cells and control P19 cells again and monitored 
AICD-induced changes in expressions of more than 20,000 independent genes by DNA 
microarray analysis at 3 time points during culture: the undifferentiated state, after 4 days of 
aggregation with RA (aggregated state), and 2 days after replating (differentiated state) 
(Ohkawara et al. 2011). Surprisingly, AICD can change expressions of a great many genes: 
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the expression levels of 277 genes were upregulated by more than 10-fold in the presence of 
AICD, while 341 genes showed downregulation of expression to less than 10% of the 
original level (Fig.6). 
 
Venn diagrams showing the total numbers of genes upregulated by more than 10-fold in the presence of 
AICD (A) and genes downregulated to less than 10% of their original level (B) at three states of neural 
differentiation in P19 cells: undifferentiated, aggregated, and differentiated. 
Fig. 6. Upregulated and downregulated genes by AICD. 
AICD strongly induced expressions of several genes. For example, AICD-overexpressing 
P19 cells showed strong expression of protein tyrosine phosphatase receptor T (Ptprt) gene 
at all sampling points: 906-fold, 204-fold, and 116-fold upregulation, in undifferentiated, 
aggregated, and differentiated states, respectively, estimated from the intensity of 
www.intechopen.com
 
Neural Stem Cells and Therapy 
 
178 
hybridization signals. In contrast to these upregulated genes, AICD also strongly inhibited 
the expression of several genes (Ohkawara et al. 2011). For example, Hes5 was markedly 
increased through the process of neural differentiation: an increase of almost 300-fold in 
control P19 cells. However, this extreme induction in control P19 cells could not be detected 
in AICD-overexpressing P19 cells, indicating that AICD inhibits this induction. These results 
show that AICD induces both upregulation and downregulation of many genes, suggesting 
that AICD plays an important role in APP signaling. 
We performed Gene Ontology (GO) analysis and classified these upregulated and 
downregulated genes according to GO terms (Ohkawara et al. 2011). While a few genes were 
classified into GO terms related to cell death, many genes were classified into GO terms 
unrelated to cell death. Furthermore, we evaluated AICD-induced changes in expression of 
genes thought to be involved in cell death in AD; however, we found no significant changes 
in expression of these genes. Therefore, it is likely that AICD does not directly induce the 
expression of genes involved in cell death, but the extreme dynamic changes in gene 
expression disrupt the homeostasis of certain neurons and thus give rise to neuron-specific 
cell death. 
4.4 Amyloid hypothesis 
Genetic studies indicate that both APP itself and its proteolytic processing are responsible 
for the onset of AD (Nakayama et al. 2011). The amyloid hypothesis is generally accepted 
as the mechanism of the onset of AD. The traditional amyloid hypothesis is that 
overproduced A forms insoluble amyloid plaques, which are commonly observed in the 
AD brain and are believed to be the toxic form of APP responsible for neurodegeneration 
(Hardy and Selkoe 2002). 
However, several issues have been raised regarding these hypotheses. One of the most 
significant arguments against the amyloid hypothesis is the presence of high levels of A 
deposition in many non-demented elderly people (Terry RD 1999). This observation implies 
that A amyloid plaques are not toxic. Based on these observations, the interesting 
possibility has been proposed that AD may be caused by an APP-derived protein, other than 
A (Schnabel 2009). As both extracellular fragment and AICD are generated at the same 
time as A, acceleration of proteolytic processing leads to overproduction of not only A but 
also of both extracellular fragment and AICD. Therefore, it is likely that neuron-specific 
apoptosis induced by AICD may also be involved in the onset of AD. 
5. Conclusion 
Although -secretase plays central roles in AD, the physiological functions of this enzyme 
have yet to be fully elucidated. As reviewed here, Notch signaling is controlled by -
secretase: intramembrane cleavage of Notch by -secretase serves to release ICD that has 
activity in the nucleus through binding to transcription factors. Recently, it was reported 
that many type 1 transmembrane proteins are substrates for -secretase, and ICDs of these 
substrates are released from the cell membrane by -secretase. These observations that the 
common enzyme, -secretase, modulates proteolysis and the turnover of possible signaling 
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molecules have led to the attractive hypothesis that mechanisms similar to the Notch 
signaling pathway may widely contribute to -secretase-regulated signaling pathways. 
Indeed, APP signaling induces dynamic changes in gene expression, which may be closely 
correlated with AICD-induced neuron-specific apoptosis and the onset of AD. Thus, it is 
likely that -secretase controls Notch signaling in NSCs and APP signaling in neurons that 
may lead to the onset of AD. 
6. Abbreviations 
AD Alzheimer’s disease 
APP amyloid precursor protein 
AICD the intracellular domain of APP  
Aph-1 anterior pharynx defective-1 
bHLH basic helix-loop-helix 
BMP bone morphogenic protein 
CTF C-terminal fragment 
Dll Delta-like protein 
Dll1IC the intracellular domain of Dll1 
EGF epidermal growth factor 
FAD familial AD 
GO gene ontology 
Hes Hairy/Enhancer of split 
ICD intracellular domain 
IDE insulin-degrading enzyme 
JM juxtamembrane 
Mib Mind bomb 
NCT nicastrin 
Ngn2 Neurogenin2 
NICD the intracellular domain of Notch 
NSC neural stem cell 
NTF N-terminal fragment 
Pen-2 PS enhancer-2 
PS presenilin 
RA all-trans-retinoic acid 
RIP the regulated intramembrane proteolysis 
TM transmembrane 
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